Ovarian Cancer Makes Noise

The American Cancer Society estimates approximately 22,240 new cases of ovarian cancer will be diagnosed in 2018, and 14,070 deaths in the US will be attributed to the disease. September is Ovarian Cancer Awareness Month, and the National Ovarian Cancer Coalition is leading efforts to better educate women about this "silent" cancer.

Although referred to as silent, women with ovarian cancer report experiencing symptoms. Unfortunately, these symptoms — bloating, pelvic or abdominal pain, eating difficulties or feeling full quickly, and frequent or urgent urination — are nonspecific and no early detection tests have been developed to date. As a result, ovarian cancer is often diagnosed at later stages when prognosis is not as good. Consider ovarian cancer in the differential diagnosis when women present with these and other nondescript symptoms (fatigue, upset stomach or heartburn, back pain, pain during sex, constipation or menstrual changes) that are new or persist for more than 2 weeks.

Effective treatment options are available, but recurrence is common, sometimes occurring months or years after completing treatment. In this selection of articles, the editors present reports on treatment options for advanced primary and recurrent ovarian cancer.

Visit Oncology Nurse Advisor to read these and many more articles.

Articles of Interest
Primary Cytoreductive Surgery for HGSC Offers Better Survival Than Neoadjuvant Chemotherapy
Long-Term Benefits Seen With Trabectedin With PLD for Recurrent Ovarian Cancer
Rucaparib Granted FDA Approval for Some Recurring Abdominal Cancers

Treating Polycythemia Vera With Ruxolitinib: A Case Study

Hydroxyurea therapy didn't prevent the need for phlebotomy, so ruxolitinib was initiated. Where do things stand now? Find out now.

To access additional articles about ovarian cancer, please click here.